← FDA DRUG APPROVALS

FDA ANDA · ANDA077447

MOMETASONE FUROATE

Sponsor: COSETTE PHARMS NC

APPLICATION
ANDA077447
TYPE
ANDA
ORIGINAL APPROVAL
2006-05-22
LATEST ACTION
2023-06-28
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

MOMETASONE FUROATEPrescription
MOMETASONE FUROATE 0.1% · CREAM · TOPICAL

Approval history

2023-06-28Labeling · Supplement 11 · standardAP
2006-05-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →